ehave Inc (OTCMKTS: EHVVF), a key player in the psychedelic and mental health space, announced that Dr. Bankole A. Johnson agreed to be a part of the Company’s Medical Advisory Board.
Strengthen its analytical platform: Dr. Bankole, a former member of the National Institute on Drug Abuse (NIDA) and National Advisory Council on Drug Abuse (NACDA), brings strong medication experience for treating addictions. Dr. Bankole will be advising and assisting ehave on human trials for psychedelic opportunities. He will also assist the company on the mental health analytical platform. As per the street, it is believed that joining Dr. Bankole on the ehave Medical Advisory Board strengthens the company’s position in the analytical platform.
Dr. Bankole A. Johnson: Dr. Bankole is a certified physician and psychiatrist throughout the United States and Europe. His expertise is in the psychopharmacology of medications for treating addictions. He is currently a member of the Extramural Advisory Board for NIH/NIAAA. For his area of work, Dr. Bankole has won several prestigious Governors awards. Dr. Johnson was also the founder of Adial Pharmaceuticals and currently acts as its Chief Medical officer. Adial Pharmaceuticals Inc (NASDAQ: ADIL) indicated that its phase 3 trial meets its screening targets and is near completion. Adil is evaluating a treatment for Alcohol Use Disorder with a specific type of genre.
It is believed that Dr. Johnson’s expertise will help the company work towards psychedelic therapies for patients who are experiencing addictions. The company is fortunate to strengthen its Medical Advisory Board in its health care journey. With the help of Dr. Johnson’s expertise, the company understands the behavior of drug-seeking patients and will develop an effective treatment in the time to come. ehave is primarily focusing on improving the standard care in therapeutics to treat or prevent brain disorders. The company’s main product is the “Ehave Dashboard,” a mental health informatics platform that allows clinicians to make intelligent decisions using Blockchain technology.